Pediatric diabetes mellitus hospitalizations and COVID-19 pandemic response measures

被引:0
|
作者
Shimony, Hope [1 ]
Miller, Lauren [1 ]
Reich, Patrick [2 ]
Banull, Nicholas R. [1 ]
Burch, Maureen [3 ]
Bryan, Melanie [1 ]
Arbelaez, Ana Maria [1 ,4 ]
机构
[1] Washington Univ, Pediat Endocrinol, Sch Med, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Pediat Infect Dis, St Louis, MO 63110 USA
[3] St Louis Childrens Hosp, Certified Diabet Educ Program, St Louis, MO USA
[4] Washington Univ, Pediat Endocrinol & Diabet Div, Sch Med, 660 South Euclid, Campus Box 8116, St Louis, MO 63110 USA
基金
美国国家卫生研究院;
关键词
Diabetes Mellitus; Children; COVID-19; Diabetic Ketoacidosis; Social Vulnerability; UNITED-STATES; SARS-COV-2; SEROPREVALENCE; CHILDREN; VACCINE; TYPE-1; TRENDS;
D O I
10.1016/j.diabres.2023.111060
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: In the United States, evidence suggests that during the COVID-19 pandemic, admissions of patients with diabetes mellitus (DM) have increased. This study assessed hospital admission rates for pediatric type 1 (T1DM) and type 2 (T2DM) diabetes mellitus during 2019-2021, and the potential influence of the timing of various pandemic response measures. Methods: Retrospective chart reviews were conducted of 854 T1DM and 135 T2DM hospital admissions between January 2019 and December 2021 in patients < 20 years old to collect demographic data, admission type, body mass index (BMI), and area deprivation index (ADI, a measure of socioeconomic vulnerability). Patients were divided into three cohorts based on their admission year: 2019 (Pre-pandemic), 2020 (Pandemic, Pre-vaccine), and 2021 (Pandemic, Post-vaccine). Admissions were categorized within each cohort by diagnosis (T1DM or T2DM) and clinical presentation (new onset, diabetic ketoacidosis: DKA). Cohorts were compared using an independent samples t-test for continuous variables or a chi-square test for categorical variables. Results: The incidence of T2DM hospitalizations tripled during the pandemic, increasing from 18 in 2019 (Prepandemic), to 55 in 2020 (Pandemic, Pre-vaccine), and 62 in 2021 (Pandemic, Post-vaccine). The rate of patients presenting with DKA was 15.4 % (95 % CI: 4 %-26.9 %) higher in 2020 (Pandemic, Pre-vaccine) among patients with new-onset T1DM (72/139 vs. 52/143), and 22.5 % (95 % CI: 9.6 %-35.4 %) higher in 2020 (Pandemic, Prevaccine) among T2DM patients (9/40 vs. 0/14). This increased rate of new onset T2DM significantly correlated with younger age (P = 0.046) and higher ADI score (P = 0.017), but not with BMI. Conclusion: The incidence of T1DM hospitalizations did not increase during the pandemic; however, they tripled for T2DM patients. All new onset DM pediatric patients during the pandemic were more likely to present in DKA. Patients admitted with new onset T2DM were socioeconomically more vulnerable. For T1DM, the peak of local pediatric diabetes admissions in 2020 occurred slightly later coinciding with the reopening of primary care physicians (PCP) offices and schools.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Diabetes and the COVID-19 pandemic
    Khunti, Kamlesh
    Valabhji, Jonathan
    Misra, Shivani
    DIABETOLOGIA, 2023, 66 (02) : 255 - 266
  • [22] Control of type 2 diabetes mellitus during the COVID-19 pandemic
    Felix, Holly C.
    Andersen, Jennifer A.
    Willis, Don E.
    Malhis, Joseph R.
    Selig, James P.
    McElfish, Pearl A.
    PRIMARY CARE DIABETES, 2021, 15 (05) : 786 - 792
  • [23] COVID-19 and diabetes mellitus: how one pandemic worsens the other
    William S. Azar
    Rachel Njeim
    Angie H. Fares
    Nadim S. Azar
    Sami T. Azar
    Mazen El Sayed
    Assaad A. Eid
    Reviews in Endocrine and Metabolic Disorders, 2020, 21 : 451 - 463
  • [24] Pediatric Diabetes on the Rise: Trends in Incident Diabetes During the COVID-19 Pandemic
    Modarelli, Rachel
    Sarah, Salma
    Ramaker, Megan E.
    Bolobiongo, Mboli
    Benjamin, Robert
    Balikcioglu, Pinar Gumus
    JOURNAL OF THE ENDOCRINE SOCIETY, 2022, 6 (04)
  • [25] Diabetic ketoacidosis in youth with diabetes mellitus during the COVID-19 pandemic
    Cymbaluk, Anna
    Huang, Xiaofan
    Minard, Charles
    Desalvo, Daniel
    Redondo, Maria J.
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2024, 37 (09): : 759 - 763
  • [26] The Nutritional and Health Effects of the COVID-19 Pandemic on Patients with Diabetes Mellitus
    Grabia, Monika
    Markiewicz-Zukowska, Renata
    Puscion-Jakubik, Anna
    Bielecka, Joanna
    Nowakowski, Patryk
    Gromkowska-Kepka, Krystyna
    Mielcarek, Konrad
    Socha, Katarzyna
    NUTRIENTS, 2020, 12 (10) : 1 - 15
  • [27] The Diagnosis and Management of Gestational Diabetes Mellitus in the Context of the COVID-19 Pandemic
    McIntyre, H. David
    Moses, Robert G.
    DIABETES CARE, 2020, 43 (07) : 1433 - 1434
  • [28] Gestational Diabetes Mellitus: increased incidence during the COVID-19 pandemic
    Boutrid, Hala
    Boutrid, Nada
    Chaat, S.
    Keghouche, M.
    Rahmoune, H.
    Madaci, F.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2022, 128 : S48 - S49
  • [29] Trends in Pediatric Hospitalizations and Mortality during the COVID-19 Pandemic in an Urban Setting in Cameroon
    Chiabi, Andreas
    Forgwei, Mfie Nji
    Bissong, Marie
    Niba, Loveline
    Abah, Jevis Ning
    Nsame, Denis
    JOURNAL OF TROPICAL PEDIATRICS, 2022, 68 (03)
  • [30] COVID-19 and diabetes mellitus: how one pandemic worsens the other
    Azar, William S.
    Njeim, Rachel
    Fares, Angie H.
    Azar, Nadim S.
    Azar, Sami T.
    El Sayed, Mazen
    Eid, Assaad A.
    REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2020, 21 (04): : 451 - 463